---
title: "Biora Therapeutics exits restructuring as a private company, securing funding to advance BioJet™ platform."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236663038.md"
description: "Following a restructuring process, Biora has transitioned into a privately owned company, securing long-term financing to expedite the advancement of the BioJet™ platform. This move positions the company to drive growth and innovation while operating as a private entity. Through this development, Biora aims to enhance its efforts in further developing the BioJet™ platform."
datetime: "2025-04-19T23:07:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236663038.md)
  - [en](https://longbridge.com/en/news/236663038.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236663038.md)
generator: "portal-rs"
---

# Biora Therapeutics exits restructuring as a private company, securing funding to advance BioJet™ platform.

Following a restructuring process, Biora has transitioned into a privately owned company, securing long-term financing to expedite the advancement of the BioJet™ platform. This move positions the company to drive growth and innovation while operating as a private entity. Through this development, Biora aims to enhance its efforts in further developing the BioJet™ platform.

### Related Stocks

- [BIOR.US](https://longbridge.com/en/quote/BIOR.US.md)
- [BIORQ.US](https://longbridge.com/en/quote/BIORQ.US.md)

## Related News & Research

- [11:39 ETNOTICE OF THE ANNUAL GENERAL MEETING OF BIORETEC LTD](https://longbridge.com/en/news/283378849.md)
- [AI HealthTech Biorce Opens U.S. Offices in Austin to Accelerate Global Expansion](https://longbridge.com/en/news/281897553.md)
- [BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform](https://longbridge.com/en/news/281896965.md)
- [Bora Biologics Successfully Completes 2,000L Engineering and Scale-Up Run in San Diego, Reinforcing Commercial-Scale Readiness](https://longbridge.com/en/news/281757479.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**